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It is now well established that the fate 
of a somatic cell is not fixed rigidly and 
that there is a significant degree of cell 
plasticity. The term plasticity refers to 
the opportunity to change differentiated 
cells from one cell type to another. Over 
the past 25 years a series of papers have 
each demonstrated that plasticity is 
wider than had previously been under-
stood [1-4]. An exciting recent article by 
Thomas Vierbuchen and colleagues at 
Stanford University extended that series 
by describing a method for directly re-
programming mouse fibroblast cells into 
neurons without the need to generate a 
stem cell intermediary [5].
Vierbuchen and colleagues isolated 
fibroblasts from embryos (mouse em-
bryonic fibroblasts – MEFs) and postna-
tal tail-tips from transgenic (TauEGFP 
knock-in) mice. TauEGFP reporter mice 
express the green fluorescent protein 
in post-mitotic neurons thus allowing 
visualisation of motor and sensory 
neuronal cells as they develop, aiding 
the identification of successful repro-
gramming. A drug-inducible lentiviral 
system containing 19 candidate genes 
selected as being either expressed in 
neural cell types or essential for repro-
gramming to pluripotency was used to 
reprogramme fibroblast to a neuronal 
state. From this group five factors that 
were able to evoke a neuronal pheno-
type were Brn2, Myt1l, Zic1, Olig2 and 
Ascl1. They termed the reprogrammed 
cells induced neuronal (iN) cells. The 
findings demonstrate MEF-derived iN 
cells (i) express neuron-specific mark-
ers including Tuj-1, MAP2, NeuN, 
Synapsin and GABA and (ii) exhibit 
functional neuronal properties includ-
ing the generation of action potentials 
and formation of functional synapses. 
Similar results were obtained when 
postnatal tail-tip fibroblast (TTF) cells 
were reprogrammed. By sequentially 
reducing the number of transcription 
factors Vierbuchen et al. [5] identified 
a combination of just three genes, Brn2, 
Myt1l, and Ascl1, that were capable of 
inducing neurons from TTF and MEFs. 
Neuronal induction was both fast and ef-
ficient in comparison to reprogramming 
to pluripotent cells [1] with cells exhib-
iting an immature neuron-like morphol-
ogy as early as 3 days post-infection and 
reprogramming efficiency rates of up to 
19.5%. In light of this high efficiency, 
it is very unlikely that the observations 
are the result of directed differentiation 
of rare stem or precursor cells. 
The demonstration of both rapid and 
efficient conversion of fibroblasts to a 
population of predominantly excitatory 
cortical neurons reaffirms that somatic 
cell populations are not fixed and indeed 
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Figure 1 Restricted lineage reprogramming. An example of restricted trans-
differentiation is when the transcription factor MyoD is ectopically expressed in 
dermal fibroblasts (Mesoderm) converting them to muscle (Mesoderm). When 
this experiment was repeated in other lineages, namely Ectoderm or Endoderm, 
no conversion to muscle was observed but activation of some muscle specific 
genes was observed. This observation is not an isolated case, the conversion of 
exocrine cell within the pancreas to an endocrine phenotype by the expression 
of three factors (not shown) [10]. Therefore there is a necessity to demonstrate 
unequivocally the conversion of one lineage to another utilising defined cell 
types.
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have huge plasticity. This observation 
is particularly exciting because of the 
possibility that the change was between 
two different lineages, mesoderm to 
ectoderm, although this is not discussed 
in detail by the authors in the original 
article itself [5]. There is a degree of 
uncertainty because the starting material 
was a heterogeneous cell population, 
probably containing both mesoderm 
and ectoderm. Thus, the resulting iN 
cells may have been derived from a 
population within the same lineage i.e. 
ectoderm. 
The current literature landscape sug-
gested that change is restricted to within 
the same lineage when employing forced 
expression of transcription factors. For 
example (see Figure 1), expression of 
MyoD converts fibroblasts (mesoderm) 
to myotubes (mesoderm) [6] whilst 
this conversion is not observed in he-
patocytes (endoderm) or keratinocytes 
(ectoderm) [7, 8]. One could speculate 
that this is a consequence of plasticity 
within that tissue lineage itself. The 
issue of trans-differentiation between 
lineages (inter-) will only be resolved as 
and when a defined cell population such 
as CD45+ cells from blood (mesoderm) 
is successfully re-assigned to another 
cellular identity for example a neuron 
(ectoderm). While some change may be 
directed by transcription factors alone, 
typically the process is slow and inef-
ficient as it requires more than a week 
and changes only a small proportion 
of the cells. By contrast, somatic cell 
nuclear transfer and cell fusion bring 
about change more efficiently and 
within 24 and 48 h, respectively [2, 9]. 
It is not clear whether this difference 
reflects the influence of other factors 
or the presence of a greater concentra-
tion of transcription factors within the 
nucleus. It remains to be shown whether 
or not transcription factors alone are 
able to direct change between lineages 
or will require the involvement of other 
factors.
The experiments described by Vi-
erbuchen et al., gave rise by default to 
a specific population of neurons. The 
authors speculate that expression of 
specific subsets of factors as yet not 
identified may generate populations 
of multipotent progenitors, such as 
neural stem cells, which in turn could 
be efficiently patterned to multiple 
neuronal cell types. The use of integra-
tive lentivirus will limit its application 
for therapeutic approaches. However, 
as with the iPS approaches, there is a 
concerted effort to eliminate the use of 
genome alteration by utilising alterna-
tive methods such as employing small 
molecules to mimic the effect of the 
transcription factors. These in turn could 
be translated to this model system.
Therefore the ability to translate this 
methodology directly to the human 
situation by converting donor somatic 
tissue of a defined identity, to a cell type 
afflicted with a cellular degeneration 
would benefit both modelling of hu-
man disease and aid drug discovery. In 
addition, this approach is not restricted 
to the generation of neurons but could 
potentially be applied to generate other 
cell types as and when the key tran-
scriptional cues are determined. To fully 
realise this technology, a concerted ef-
fort will be required to demonstrate the 
ability to accurately induce alteration 
of lineage fate as to reflect the in vivo 
cellular equivalent!
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